• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病对骨质疏松症的因果影响:一项孟德尔随机化研究。

Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study.

机构信息

Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, China.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

出版信息

Front Endocrinol (Lausanne). 2023 Dec 12;14:1283739. doi: 10.3389/fendo.2023.1283739. eCollection 2023.

DOI:10.3389/fendo.2023.1283739
PMID:38149094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10749958/
Abstract

BACKGROUND

Osteoporosis (OP) is a systemic skeletal disease characterized by compromised bone strength leading to an increased risk of fracture. There is an ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the pathogenesis of OP. The aim of this study was to assess the causal association between NAFLD and OP.

METHODS

We performed two-sample Mendelian randomization (MR) analyses to investigate the causal association between genetically predicted NAFLD [i.e., imaging-based liver fat content (LFC), chronically elevated serum alanine aminotransferase (cALT) and biopsy-confirmed NAFLD] and risk of OP. The inverse variant weighted method was performed as main analysis to obtain the causal estimates.

RESULTS

Imaging-based LFC and biopsy-confirmed NAFLD demonstrated a suggestive causal association with OP ([odds ratio (OR): 1.003, 95% CI: 1.001-1.004, P < 0.001; OR: 1.001, 95% CI: 1.000-1.002, P = 0.031]). The association between cALT and OP showed a similar direction, but was not statistically significant (OR: 1.001, 95% CI: 1.000-1.002, P = 0.079). Repeated analyses after exclusion of genes associated with confounding factors showed consistent results. Sensitivity analysis indicated low heterogeneity, high reliability and low pleiotropy of the causal estimates.

CONCLUSION

The two-sample MR analyses suggest a causal association between genetically predicted NAFLD and OP.

摘要

背景

骨质疏松症(OP)是一种全身性骨骼疾病,其特征是骨强度受损,导致骨折风险增加。目前,关于非酒精性脂肪性肝病(NAFLD)是否是 OP 发病机制中的一个积极因素还是无辜的旁观者,仍存在争议。本研究旨在评估 NAFLD 与 OP 之间的因果关系。

方法

我们进行了两样本 Mendelian 随机化(MR)分析,以研究遗传预测的 NAFLD[即基于影像学的肝脂肪含量(LFC)、慢性升高的血清丙氨酸氨基转移酶(cALT)和活检证实的 NAFLD]与 OP 风险之间的因果关系。反变量加权法作为主要分析方法来获得因果估计。

结果

基于影像学的 LFC 和活检证实的 NAFLD 与 OP 之间显示出提示性的因果关联(比值比[OR]:1.003,95%置信区间[CI]:1.001-1.004,P < 0.001;OR:1.001,95%CI:1.000-1.002,P = 0.031])。cALT 与 OP 之间的关联也呈现出相似的方向,但没有统计学意义(OR:1.001,95%CI:1.000-1.002,P = 0.079)。排除与混杂因素相关的基因后进行重复分析,结果一致。敏感性分析表明,因果估计具有低异质性、高可靠性和低多效性。

结论

两样本 MR 分析表明,遗传预测的 NAFLD 与 OP 之间存在因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/1f1a29036c4f/fendo-14-1283739-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/43011096ac50/fendo-14-1283739-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/8b79c3e5702a/fendo-14-1283739-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/1f1a29036c4f/fendo-14-1283739-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/43011096ac50/fendo-14-1283739-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/8b79c3e5702a/fendo-14-1283739-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1e/10749958/1f1a29036c4f/fendo-14-1283739-g003.jpg

相似文献

1
Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study.非酒精性脂肪性肝病对骨质疏松症的因果影响:一项孟德尔随机化研究。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1283739. doi: 10.3389/fendo.2023.1283739. eCollection 2023.
2
Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.非酒精性脂肪性肝病与冠状动脉疾病的关系:一项孟德尔随机化研究。
Hepatology. 2023 Jan 1;77(1):230-238. doi: 10.1002/hep.32534. Epub 2022 May 18.
3
Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.1 型和 2 型糖尿病中非酒精性脂肪性肝病及其并发症的孟德尔随机研究。
Diabetes Obes Metab. 2023 Feb;25(2):365-376. doi: 10.1111/dom.14877. Epub 2022 Nov 2.
4
A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.两样本孟德尔随机化分析排除了非酒精性脂肪性肝病与肾结石之间的因果关系。
Front Endocrinol (Lausanne). 2024 Jan 10;14:1343367. doi: 10.3389/fendo.2023.1343367. eCollection 2023.
5
Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study.非酒精性脂肪性肝病与骨质疏松症、骨折和跌倒风险的因果关系:一项双向孟德尔随机研究。
Front Endocrinol (Lausanne). 2023 Aug 9;14:1215790. doi: 10.3389/fendo.2023.1215790. eCollection 2023.
6
Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.睡眠呼吸暂停与非酒精性脂肪性肝病之间的因果关系:一项孟德尔随机化研究。
Eur J Clin Invest. 2024 Mar;54(3):e14116. doi: 10.1111/eci.14116. Epub 2023 Nov 2.
7
Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study.探讨欧洲人群中强直性脊柱炎与骨质疏松症之间的因果关系:一项双向孟德尔随机化研究。
Front Immunol. 2023 Jun 8;14:1163258. doi: 10.3389/fimmu.2023.1163258. eCollection 2023.
8
Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.1 型糖尿病和非酒精性脂肪性肝病:两样本孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Apr 12;15:1315046. doi: 10.3389/fendo.2024.1315046. eCollection 2024.
9
The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study.孟德尔随机化研究表明,非酒精性脂肪性肝病对骨密度的影响由硬化素介导。
Calcif Tissue Int. 2024 May;114(5):502-512. doi: 10.1007/s00223-024-01204-5. Epub 2024 Mar 31.
10
The causal associations of non-alcoholic fatty liver disease with blood pressure and the mediating effects of cardiometabolic risk factors: A Mendelian randomization study.非酒精性脂肪性肝病与血压的因果关联及心血管代谢危险因素的中介作用:一项孟德尔随机化研究。
Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2151-2159. doi: 10.1016/j.numecd.2023.07.010. Epub 2023 Jul 19.

引用本文的文献

1
Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.骨质疏松症风险和保护因素的孟德尔随机化研究:系统评价与荟萃分析
Front Endocrinol (Lausanne). 2025 Jan 16;15:1486188. doi: 10.3389/fendo.2024.1486188. eCollection 2024.
2
Mining single-cell data for cell type-disease associations.挖掘单细胞数据以寻找细胞类型与疾病的关联。
NAR Genom Bioinform. 2024 Dec 18;6(4):lqae180. doi: 10.1093/nargab/lqae180. eCollection 2024 Dec.
3
Association between nonalcoholic fatty liver disease and bone mineral density: Mendelian randomization and mediation analysis.

本文引用的文献

1
Exploring the landscape of steatotic liver disease in the general US population.探索美国普通人群中的脂肪性肝病情况。
Liver Int. 2023 Nov;43(11):2425-2433. doi: 10.1111/liv.15695. Epub 2023 Aug 17.
2
Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.非酒精性脂肪性肝病不合并代谢相关脂肪性肝病与2型糖尿病发病风险
Liver Int. 2023 Nov;43(11):2445-2454. doi: 10.1111/liv.15661. Epub 2023 Jun 30.
3
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
非酒精性脂肪性肝病与骨密度之间的关联:孟德尔随机化和中介分析
Bone Rep. 2024 Jun 26;22:101785. doi: 10.1016/j.bonr.2024.101785. eCollection 2024 Sep.
4
osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice.高脂饮食小鼠肝细胞上清液增强破骨细胞分化
Biochem Biophys Rep. 2024 Jul 13;39:101788. doi: 10.1016/j.bbrep.2024.101788. eCollection 2024 Sep.
多学会专家共识:新脂肪性肝病命名。
Ann Hepatol. 2024 Jan-Feb;29(1):101133. doi: 10.1016/j.aohep.2023.101133. Epub 2023 Jun 24.
4
Nonalcoholic Fatty Liver Disease Is Associated With Decreased Bone Mineral Density in Adults: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病与成年人骨密度降低相关:系统评价和荟萃分析。
J Bone Miner Res. 2023 Aug;38(8):1092-1103. doi: 10.1002/jbmr.4862. Epub 2023 Jun 12.
5
Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病与骨质疏松症或骨质疏松性骨折患病率及风险的关系:系统评价和荟萃分析。
Osteoporos Int. 2022 Nov;33(11):2275-2286. doi: 10.1007/s00198-022-06459-y. Epub 2022 Jun 28.
6
Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.根据世界卫生组织诊断标准的全球、区域骨质疏松症患病率及危险因素:一项系统评价和荟萃分析
Osteoporos Int. 2022 Oct;33(10):2137-2153. doi: 10.1007/s00198-022-06454-3. Epub 2022 Jun 10.
7
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.一项针对不明原因慢性 ALT 升高(作为非酒精性脂肪性肝病的替代指标)的多祖裔全基因组关联研究,通过组织学和影像学验证。
Nat Genet. 2022 Jun;54(6):761-771. doi: 10.1038/s41588-022-01078-z. Epub 2022 Jun 2.
8
Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications.非酒精性脂肪性肝病与骨质疏松症:具有治疗意义的潜在关联。
Diabetes Obes Metab. 2022 Sep;24(9):1702-1720. doi: 10.1111/dom.14774. Epub 2022 Jun 14.
9
The clinician's guide to prevention and treatment of osteoporosis.临床医生骨质疏松症防治指南。
Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y. Epub 2022 Apr 28.
10
Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease.TM6SF2 rs58542926 多态性与非酒精性脂肪性肝病关系的研究进展。
Expert Rev Gastroenterol Hepatol. 2022 Feb;16(2):97-107. doi: 10.1080/17474124.2022.2032661. Epub 2022 Jan 31.